COLL vs INVH · P/E 17, rev $181.9M vs P/E 42, rev $2.62B
Collegium Pharmaceutical Inc (COLL) versus Invitation Homes Inc (INVH) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Not investment advice. Open the COLL and INVH stock pages for the full models.
Not investment advice.